Apogee Therapeutics Inc. (APGE)
NASDAQ: APGE
· Real-Time Price · USD
37.36
-0.76 (-1.99%)
At close: Aug 15, 2025, 3:59 PM
36.48
-2.36%
After-hours: Aug 15, 2025, 07:58 PM EDT
Apogee Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
Cash & Equivalents | 124.19M | 106.92M | 141.79M | 118.78M | 307.3M | 485.46M | 118.32M | 188.27M | 125.07M | 141.33M | 151.89M | n/a |
Short-Term Investments | 381.23M | 406.41M | 378.86M | 407.27M | 368.93M | 330.74M | 277.14M | 234.59M | n/a | n/a | n/a | n/a |
Long-Term Investments | 116.07M | 168.11M | 210.42M | 227.75M | 113.39M | 294K | 300K | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 8.56M | 7.34M | 498K | 514K | 468K | 107K | 101K | 200K | n/a | n/a | n/a | n/a |
Receivables | 4.14M | 5.01M | 4.7M | 4.77M | n/a | n/a | 1.21M | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 6.57M | 586K | 1.74M | 396K | 3.39M | 2.72M | n/a | 1.41M | 4.36M | 529K | 57K | n/a |
Total Current Assets | 516.12M | 521.53M | 529.71M | 534.48M | 681.85M | 820.61M | 398.41M | 426.42M | 130.67M | 142.02M | 152.06M | n/a |
Property-Plant & Equipment | 17.02M | 17.19M | 13.32M | 13.54M | 4.94M | 2.65M | 2.59M | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 141.65M | 192.63M | 224.24M | 241.8M | 118.8M | 3.05M | 3M | 200K | 3.47M | n/a | n/a | n/a |
Total Assets | 657.77M | 714.16M | 753.95M | 776.29M | 800.66M | 823.66M | 401.4M | 426.42M | 130.67M | 142.02M | 152.06M | n/a |
Account Payables | 5.68M | 2.44M | 1.07M | 2.22M | 5.53M | 4.3M | 2.14M | 1.21M | 11.15M | 965K | 418K | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 4.03M | n/a | n/a | n/a | 1.68M | 1.14M | 1.1M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 13.69M | 5.22M | 1.9M | 27.53M | -1.68M | -1.14M | 16.05M | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 31.55M | 32.96M | 28.56M | 32.61M | 24.62M | 21.55M | 20.56M | 17.18M | 17.61M | 11.19M | 9.98M | n/a |
Long-Term Debt | 6.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 6.82M | 7.84M | 8.6M | 9.27M | 2.4M | 630K | 933K | n/a | 177.47M | n/a | n/a | n/a |
Total Liabilities | 38.37M | 40.8M | 37.16M | 41.88M | 27.02M | 22.18M | 21.49M | 17.18M | 195.08M | 11.19M | 9.98M | n/a |
Total Debt | 10.85M | 11.82M | 11.83M | 12.14M | 4.08M | 1.77M | 2.03M | n/a | n/a | n/a | n/a | n/a |
Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | n/a | n/a | 2.25K | 2.25K | 2.25K | n/a |
Retained Earnings | -427.35M | -361.25M | -305.92M | -238.7M | -189.68M | -155.86M | -123.77M | -92.03M | -71.19M | -52.31M | -39.78M | n/a |
Comprehensive Income | 685K | 1.07M | 915K | 3.27M | -289K | -177K | 329K | 135K | 4.53K | 3.42K | 2.14K | n/a |
Shareholders Equity | 619.4M | 673.36M | 1.02B | 734.4M | 773.64M | 801.48M | 379.91M | 409.24M | -71.19M | -52.31M | -39.78M | n/a |
Total Investments | 497.3M | 574.52M | 589.28M | 635.01M | 482.32M | 331.03M | 277.44M | 234.59M | n/a | n/a | n/a | n/a |